6 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... , and sexually active ... HIV aged 21–29 should ... • Pap test should ... #HIVAIDS #pharmacology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
• Silicosis • Chronic ... malignancy, and chronic ... Tuberculosis Diagnosis ... Tuberculin skin test ... HIV-infected patients should
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
• Silicosis • Chronic ... malignancy, and chronic ... Tuberculosis Diagnosis ... Tuberculin skin test ... HIV-infected patients should
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... end-organ disease is best ... CMV retinitis should ... Therapy Followed by Chronic ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Managing Microsporidiosis in HIV-AIDS
Preventing Chronic Microsporidiosis:
 • Because chronic microsporidiosis occurs
IDSA Recommendations ... HIV-AIDS Preventing Chronic ... immunosuppressed should ... bieneusi: • The best ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... and molecular diagnostic ... treatment should ... Tuberculosis #TB #IDSA ... #HIVAIDS #pharmacology